logo
logo
AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
Flexible Plans • $39/mo or $29/mo annual
AI + real-time funding intelligence
Never see duplicates in your feed
INDUSTRY FIRST

Biotech Company GenoPalate Closes $4 Million Series A Financing-Investment In Personalized Healthy Eating Continues To Grow

Dec 30, 2020over 4 years ago

Amount Raised

$4 Million

Round Type

series a

Milwaukee

Description

GenoPalate, Inc., a Milwaukee-based early-stage nutritional genomics company, has completed a $4 million round of equity financing from local investors. This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform so the company can engage 3,000 or more new customers a day for their personal nutrition needs, which will more than double its current capacity.

Company Information

Company

Geno Palate

Location

Milwaukee, Wisconsin, United States

About

GenoPalate, Inc. empowers customers to eat better and healthier through science and personalization. GenoPalate's simple home nutrition DNA test analyzes 100+ genetic markers that determine a person's specific needs for vital nutrients such as carbohydrates, vitamin D, and sodium. That combined with millions of nutritional variables produces a personalized report recommending foods that will provide the most benefit for a person’s health.

FundzWatch™ Score

74
Medium Activity